Shanghai Yingli Pharmaceutical Co., Ltd.
PrivateLast Round
Series A++
Mar 21, 2024
Total Funding Raised
$50M
Company Overview
Shanghai Yingli Pharmaceutical Co., Ltd. is a clinical-stage biotechnology company that researches and develops innovative oral small-molecule drugs for the treatment of oncology and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Yingli Pharmaceutical Co., Ltd. Comparables
Compare Shanghai Yingli Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sino Biopharmaceutical | 81% | |
| Innovent Biologics | 81% | |
| Secura Bio | 79% |
Shanghai Yingli Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A++ | Mar 21, 2024 | ||||
| Series A Extension | Nov 8, 2023 | ||||
| Strategic | Feb 8, 2021 | ||||
| Series A | Feb 2, 2021 |
Shanghai Yingli Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series A Extension |
| 中南创投基金 | Series A |
| CICC Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2023
Raised Series A Extension round with CICC Capital and DYEE Capital.
- Feb 8, 2021
Raised $20M with Jiangsu Hengrui Pharmaceuticals Co., Ltd. as an investor.
Shanghai Yingli Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Yingli Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Yingli Pharmaceutical Co., Ltd. a public or private company?
Shanghai Yingli Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Shanghai Yingli Pharmaceutical Co., Ltd.?
Shanghai Yingli Pharmaceutical Co., Ltd. is a private company with no public stock price. Caplight tracks Shanghai Yingli Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Shanghai Yingli Pharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Shanghai Yingli Pharmaceutical Co., Ltd. is not publicly available.
Can I buy Shanghai Yingli Pharmaceutical Co., Ltd. stock?
Shanghai Yingli Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Yingli Pharmaceutical Co., Ltd.'s last funding round?
Shanghai Yingli Pharmaceutical Co., Ltd.'s most recent funding round was Series A++ on March 21, 2024.
Who are the main investors in Shanghai Yingli Pharmaceutical Co., Ltd.?
Key investors in Shanghai Yingli Pharmaceutical Co., Ltd. include 中南创投基金.
Will Shanghai Yingli Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Yingli Pharmaceutical Co., Ltd..
How can I track Shanghai Yingli Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Yingli Pharmaceutical Co., Ltd.'s secondary market activity and sign up for updates.